| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 410.95M | 360.10M | 359.75M | 322.17M | 323.85M |
| Gross Profit | 357.44M | 226.42M | 214.31M | 269.81M | 266.77M |
| EBITDA | 125.37M | 100.37M | 92.71M | 77.48M | 113.69M |
| Net Income | 74.36M | 62.19M | 46.89M | 41.44M | 71.48M |
Balance Sheet | |||||
| Total Assets | 1.01B | 731.98M | 716.86M | 586.42M | 646.81M |
| Cash, Cash Equivalents and Short-Term Investments | 392.23M | 328.22M | 211.19M | 176.79M | 191.07M |
| Total Debt | 68.41M | 14.34M | 16.91M | 11.82M | 14.45M |
| Total Liabilities | 550.69M | 314.01M | 313.37M | 212.41M | 277.93M |
| Stockholders Equity | 457.08M | 417.97M | 403.49M | 374.01M | 368.88M |
Cash Flow | |||||
| Free Cash Flow | 45.74M | 166.25M | 60.21M | 42.94M | 140.27M |
| Operating Cash Flow | 49.03M | 175.35M | 80.08M | 71.16M | 156.08M |
| Investing Cash Flow | -13.05M | -41.35M | -41.57M | -31.16M | -17.64M |
| Financing Cash Flow | -13.05M | -41.31M | -21.01M | -69.06M | -82.16M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | £3.15B | 15.42 | 47.78% | 4.70% | 0.05% | 6.54% | |
76 Outperform | £6.00B | 12.71 | 26.63% | 3.62% | ― | ― | |
73 Outperform | £1.03B | 18.52 | 14.91% | 4.65% | 16.10% | 19.10% | |
73 Outperform | £2.18B | 12.59 | 9.39% | 6.35% | 4.73% | 15.14% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
51 Neutral | £670.22M | -22.43 | -9.28% | ― | -18.61% | 48.41% |